Two faces of p53: Aging and tumor suppression

Nucleic Acids Research

Volumn 35, Issue 22, 2007, Pages 7475-7484

  Rodier, Francis ^a,b   Campisi, Judith ^a,b   Bhaumik, Dipa ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CELL PROTEIN; DOUBLE STRANDED DNA; LAMIN A; METALLOPROTEINASE; PROTEIN KU80; PROTEIN MDM2; PROTEIN P53; TELOMERASE; UNCLASSIFIED DRUG; ZMPSTE24 PROTEINASE;

AGING; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL AGING; CELL CYCLE ARREST; CELL FATE; CELL PROLIFERATION; DNA DAMAGE; DNA STRAND BREAKAGE; EXCISION REPAIR; GENE MUTATION; GENETIC REGULATION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; LONGEVITY; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RISK REDUCTION; SIGNAL TRANSDUCTION; STEM CELL; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; CELL AGING; DNA DAMAGE; HUMANS; LONGEVITY; MICE; MODELS, ANIMAL; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 38048999665     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm744     Document Type: Article

References (102)

1. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
2. Campisi,J. (2003) Cancer and ageing: Rival demons? Nat. Rev., 3 339-349.
3. Vijg,J. and Suh,Y. (2005) Genetics of longevity and aging. Annu. Rev. Med., 56, 193-212.
4. Tyner,S.D., Venkatachalam,S., Choi,J., Jones,S., Ghebranious,N., Igelmann,H., Lu,X., Soron,G., Cooper,B. et al. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature, 415, 45-53.
5. Dumble,M., Moore,L., Chambers,S.M., Geiger,H., Van Zant,G., Goodell,M.A. and Donehower,L.A. (2007) The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging. Blood, 109, 1736-1742.
6. Maier,B., Gluba,W., Bernier,B., Turner,T., Mohammad,K., Guise,T., Sutherland,A., Thorner,M. and Scrable,H. (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev., 18, 306-319.
7. Balducci,L. and Ershler,W.B. (2005) Cancer and ageing: A nexus at several levels. Nat. Rev., 5, 655-662.
8. Gessert,C.E., Elliott,B.A. and Haller,I.V. (2002) Dying of old age: An examination of death certificates of Minnesota centenarians. J. Am. Geriatr. Soc., 50, 1561-1565.
9. Sedelnikova,O.A., Horikawa,I., Zimonjic,D.B., Popescu,N.C., Bonner,W.M. and Barrett,J.C. (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 6, 168-170.
10. Herbig,U., Ferreira,M., Condel,L., Carey,D. and Sedivy,J.M. (2006) Cellular senescence in aging primates. Science (New York, N. Y.), 311, 1257.
11. Jeyapalan,J.C., Ferreira,M., Sedivy,J.M. and Herbig,U. (2007) Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev., 128, 36-44.
12. Vijg,J. and Dolle,M.E. (2002) Large genome rearrangements as a primary cause of aging. Mech. Ageing Dev., 123, 907-915.
13. Bahar,R., Hartmann,C.H., Rodriguez,K.A., Denny,A.D., Busuttil,R.A., Dolle,M.E., Calder,R.B., Chisholm,G.B., Pollock,B.H. et al. (2006) Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature, 441, 1011-1014.
14. Carlson,M.E. and Conboy,I.M. (2007) Loss of stem cell regenerative capacity within aged niches. Aging Cell, 6, 371-382.
15. Rossi,D.J., Bryder,D., Seita,J., Nussenzweig,A., Hoeijmakers,J. and Weissman,I.L. (2007) Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature, 447, 725-729.
16. Matoba,S., Kang,J.G., Patino,W.D., Wragg,A., Boehm,M., Gavrilova,O., Hurley,P.J., Bunz,F. and Hwang,P.M. (2006) p53 regulates mitochondrial respiration. Science (New York, N. Y.), 312, 1650-1653.
17. Bensaad,K., Tsuruta,A., Selak,M.A., Vidal,M.N., Nakano,K., Bartrons,R., Gottlieb,E. and Vousden,K.H. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell, 126, 107-120.
18. Sablina,A.A., Budanov,A.V., Ilyinskaya,G.V., Agapova,L.S., Kravchenko,J.E. and Chumakov,P.M. (2005) The antioxidant function of the p53 tumor suppressor. Nat. Med., 11, 1306-1313.
19. Balaban,R.S., Nemoto,S. and Finkel,T. (2005) Mitochondria, oxidants, and aging. Cell, 120, 483-495.
20. Bokov,A., Chaudhuri,A. and Richardson,A. (2004) The role of oxidative damage and stress in aging. Mech. Ageing Dev., 125, 811-826.
21. Malkin,D., Li,F.P., Strong,L.C., Fraumeni,J.F.Jr, Nelson,C.E., Kim,D.H., Kassel,J., Gryka,M.A., Bischoff,F.Z. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (New York, N. Y.), 250, 1233-1238.
22. Donehower,L.A., Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A.Jr, Butel,J.S. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
23. Wu,C., Miloslavskaya,J., Demontis,S., Maestro,R. and Galaktionov,K. (2004) Regulation of cellular response to oncogenic and oxidative stress by Seladin-1. Nature, 432, 640-645.
24. Mallette,F.A., Gaumont-Leclerc,M.F. and Ferbeyre,G. (2007) The DNA damage signaling pathway is critical mediator of oncogene-induced senescence. Genes Dev., 21, 43-48.
25. Di Micco,R., Fumagalli,M., Cicalese,A., Piccinin,S., Gasparini,P., Luise,C., Schurra,C., Garre,M., Nuciforo,P.G. et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 444, 638-642.
26. Bartkova,J., Rezaei,N., Liontos,M., Karakaidos,P., Kletsas,D., Issaeva,N., Vassiliou,L.V., Kolettas,E., Niforou,K. et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 444, 633-637.
27. Green,D.R. and Chipuk,J.E. (2006) p53 and metabolism: Inside the TIGAR. Cell, 126, 30-32.
28. Bakkenist,C.J. and Kastan,M.B. (2004) Initiating cellular stress responses. Cell, 118, 9-17.
29. Zou,L. and Elledge,S.J. (2003) Sensing DNA damage through ATRIP recognition, of RPA-ssDNA complexes. Seience (New York, N.Y.), 300, 1542-1548.
30. Cortez,D. (2005) Unwind and slow down: Checkpoint activation by helicase and polymerase uncoupling. Genes Dev., 19, 1007-1012.
31. Marini,F., Nardo,T., Giannattasio,M., Minuzzo,M., Stefanini,M., Plevani,P. and Falconi,M.M. (2006) DNA nucleotide excision repair-qependent signaling to checkpoint activation. Proc. Natl Acad Sci. USA, 103, 17325-17330.
32. Jiang,G. and Sancar,A. (2006) Recruitment of DNA damage checkpoint proteins to damage in transcribed and nontranscribed sequences. Mol. Cell. Biol., 26, 39-49.
33. Bassing,C.H. and Alt,F.W. (2004) The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst), 3, 781-796.
34. Pluquet,O. and Hainaut,P. (2001) Genotoxic and non-genotoxic pathways of p53 induction. Cancer Lett., 174, 1-15.
35. Celeste,A., Petersen,S., Romanienko,P.J., Fernandez-Capetillo,O., Chen,H.T., Sedelnikova,O.A., Reina-San-Martin,B., Coppola,V., Meffre,E. et al. (2002) Genomic instability in mice lacking histone H2AX. Science (New York, N.Y.), 296, 922-927.
36. Lavin,M.F. and Gueven,N. (2006) The complexity of p53 stabilization and activation. Cell Death Differ., 13, 941-950.
37. Marchenko,N.D., Zaika,A. and Moll,U.M. (2000) Death signal-induced localization of p53 protein to mitocbondria. A potential role in apoptotic signaling. J. Biol. Chem., 275, 16202-16212.
38. Murphy,M.E., Leu,J.I. and George,D.L. (2004) p53 moves to mitochondria: a turn on the path to apoptosis. Cell cycle (Georgetown, Tex.), 3, 836-839.
39. Al Rashid,S.T., Dellaire,G., Cuddihy,A., Jalali,F., Vaid,M., Coackley,C., Folkard,M., Xu,Y., Chen,B.P. et al. (2005) Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res., 65, 10810-10821.
40. Ho,J. and Benchimol,S. (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ., 10, 404-408.
41. Oren,M. (2003) Decision making by p53: Life, death and cancer. Cell Death Differ., 10, 431-442.
42. Guillouf,C., Grana,X., Selvakumaran,M., De Luca,A., Giordano,A., Hoffman,B. and Liebermann,D.A. (1995) Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: Blocking p53-induced apoptosis unmasks G1 arrest. Blood, 85, 2691-2698.
43. Danial,N.N. and Korsmeyer,S.J. (2004) Cell death: Critical control points. Cell, 116, 205-219.
44. Lowe,S.W., Schmitt,E.M., Smith,S.W., Osborne,B.A. and Jacks,T. (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature, 362, 847-849.
45. Di Leonardo,A., Linke,S.P., Clarkin,K. and Wahl,G.M. (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8, 2540-2551.
46. Campisi,J. (2005) Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors. Cell, 120, 513-522.
47. Beausejour,C.M., Krtolica,A., Galimi,F., Narita,M., Lowe,S.W., Yaswen,P. and Campisi,J. (2003) Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J., 22, 4212-4222.
48. Kishi,S. (2004) Functional aging and gradual senescence in zebrafish. Ann. NY Acad. Sci., 1019, 521-526.
49. Melk,A., Kittikowit,W., Sandhu,I., Halloran,K.M., Grimm,P., Schmidt,B.M. and Halloran,P.F. (2003) Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int., 63, 2134-2143.
50. Dimri,G.P., Lee,X., Basile,G., Acosta,M., Scott,G., Roskelley,C., Medrano,E.E., Linskens,M., Rubelj,I. et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
51. Wang,Y., Schulte,B.A., LaRue,A.C., Ogawa,M. and Zhou,D. (2006) Total body irradiation selectively induces murine hematopoietic stem cell senescence. Blood, 107, 358-366.
52. Janzen,V., Forkert,R., Flerning,H.E., Saito,Y., Waring,M.T., Dombkowski,D.M., Cheng,T., DePinho,R.A., Sharpless,N.E. et al. (2006) Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p161NK4a. Nature, 443, 421-426.
53. Molofsky,A.V., Slutsky,S.G., Joseph,N.M., He,S., Pardal,R., Krishnamurthy,J., Sharpless,N.E. and Morrison,S.J. (2006) Increasing p161NK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature, 443, 448-452.
54. Parrinello,S., Coppe,J.P., Krtolica,A. and Campisi,J. (2005) Stromal-epithelial interactions in aging and cancer: Senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci., 118, 485-496.
55. Liu,D. and Hornsby,P.J. (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res., 67, 3117-3126.
56. Lowe,S.W., Ruley,H.E., Jacks,T. and Housman,D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74, 957-967.
57. Lotem,J. and Sachs,L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
58. Christophorou,M.A., Martin-Zanca,D., Soucek,L., Lawfor,E.R., Brown-Swigart,L., Verschuren,E.W. and Evan,G.I. (2005) Temporal dissection of p53 function in vitro and in vivo. Nat. Genet., 37, 718-726.
59. Christophorou,M.A., Ringshausen,I., Finch,A.J., Swigart,L.B. and Evan,G.I. (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature, 443, 214-217.
60. Komarova,E.A., Kondratov,R.V., Wang,K., Christov,K., Golovkina,T.V., Goldblum,J.R. and Gudkov,A.V. (2004) Dual effect of p53 on radiation sensitivity in vivo: P53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene, 23, 3265-3271.
61. Vogel,H., Lim,D.S., Karsenty,G., Finegold,M. and Hasty,P. (1999) Deletion of Ku86 causes early onset of senescence in mice. Proc. Natl Acad. Sci. USA, 96, 10770-10775.
62. DePinho,R.A. (2000) The age of cancer. Nature, 408, 248-254.
63. Kuro-o,M. (2001) Disease model: Human aging. Trends Mol. Med., 7, 179-181.
64. de Boer,J., Andressoo,J.O., de Wit,J., Huijmans,J., Beems,R.B., van Steeg,H., Weeda,G., van der Horst,G.T., van Leeuwen,W. et al. (2002) Premature aging in mice deficient in DNA repair and transcription. Science (New York, N.Y.), 296, 1276-1279.
65. Chechlacz,M., Vemuri,M.C. and Naegele,J.R. (2001) Role of DNA-dependent protein kinase in neuronal survival. J. Neurochem., 78, 141-154.
66. Lim,D.S., Vogel,H., Willerford,D.M., Sands,A.T., Platt,K.A. and Hasty,P. (2000) Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell. Biol., 20, 3772-3780.
67. Marrone,A., Walne,A. and Dokal,I. (2005) Dyskeratosis congenita: telomerase, telomeres and anticipation. Curr. Opin. Genet. Dev., 15, 249-257.
68. Rodier,F., Kim,S.H., Nijar,T., Yaswen,P. and Campisi,J. (2005) Cancer and aging: The importance of telomeres in genome maintenance. Int J. Biochem. Cell Boil., 37, 977-990.
69. d'Adda di Fagagna,F., Reaper,P.M., Clay-Farrace,L., Fiegler,H., Carr,P., Von Zglinicki,T., Saretzki,G., Carter,N.P. and Jackson,S.P. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198.
70. von Zglinicki,T., Saretzki,G., Ladhoff,J., d'Adda di Fagagna,F. and Jackson,S.P. (2005) Human cell senescence as a DNA damage response. Mech. Ageing Dev., 126, 111-117.
71. Blasco,M.A., Lee,H.W., Hande,M.P., Samper,E., Lansdorp,P.M., DePinho,R.A. and Greider,C.W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell, 91, 25-34.
72. Rudolph,K.L., Chang,S., Lee,H.W., Blasco,M., Gottlieb,G.J., Greider,C. and DePinho,R.A. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell, 96, 701-712.
73. Chin,L., Artandi,S.E., Shen,Q., Tam,A., Lee,S.L., Gottlieb,G.J., Greider,C.W. and DePinho,R.A. (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97, 527-538.
74. Sullivan,T., Escalante-Alcalde,D., Bhatt,H., Anver,M., Bhat,N., Nagashima,K., Stewart,C.L. and Burke,B. (1999) Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell. Biol., 147, 913-920.
75. Pendas,A.M., Zhou,Z., Cadinanos,J., Freije,J.M., Wang,J., Hultenby,K., Astudillo,A., Wernerson,A., Rodriguez,F. et al. (2002) Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet., 31, 94-99.
76. Bergo,M.O., Gavino,B., Ross,J., Schmidt,W.K., Hong,C., Kendall,L.V., Mohr,A., Meta,M., Genant,H. et al. (2002) Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc. Natl Acad. Sci. USA, 99, 13049-13054.
77. Chen,L., Lee,L., Kudlow,B.A., Dos Santos,H.G., Sletvold,O., Shafeghati,Y., Botha,E.G., Garg,A., Hanson,N.B. et al. (2003) LMNA mutations in atypical Werner's syndrome. Lancet, 362, 440-445.
78. Eriksson,M., Brown,W.T., Gordon,L.B., Glynn,M.W., Singer,J., Scott,L., Erdos,M.R., Robbins,C.M., Moses,T.Y. et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature, 423, 293-298.
79. Varela,I., Cadinanos,J., Pendas,A.M., Gutierrez-Fernandez,A., Folgueras,A.R., Sanchez,L.M., Zhou,Z., Rodriguez,F.J., Stewart,C.L. et al. (2005) Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature, 437 564-568.
80. Scaffidi,P. and Misteli,T. (2006) Lamin A-dependent nuclear defects in human aging. Science (New York, N.Y.), 312, 1059-1063.
81. Liu,B., Wang,J., Chan,K.M., Tjia,W.M., Deng,W., Guan,X., Huang,J.D., Li,K.M., Chau,P.Y. et al. (2005) Genomic instability in laminopathy-based premature aging. Nat. Med., 11, 780-785.
82. Zhang,J. and Powell,S.N. (2005) The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol. Cancer Res., 3, 531-539.
83. Xu,X., Qiao,W., Linke,S.P., Cao,L., Li,W.M., Furth,P.A., Harris,C.C. and Deng,C.X. (2001) Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet., 28, 266-271.
84. Cao,L., Li,W., Kim,S., Brodie,S.G. and Deng,C.X. (2003) Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev., 17, 201-213.
85. Cao,L., Kim,S., Xiao,C., Wang,R.H., Coumoul,X., Wang,X., Li,W.M., Xu,X.L., De Soto,J.A. et al. (2006) ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J., 25, 2167-2177.
86. Gentry,A. and Venkatachalam,S. (2005) Complicating the role of p53 in aging. Aging Cell, 4, 157-160.
87. Guarente,L. and Kenyon,C. (2000) Genetic pathways that regulate ageing in model organisms. Nature, 408, 255-262.
88. Bluher,M., Kahn,B.B. and Kahn,C.R. (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science (New York, N.Y.), 299, 572-574.
89. Garcia-Cao,I., Garcia-Cao,M., Martin-Caballero,J., Criado,L.M., Klatt,P., Flores,J.M., Weill,J.C., Blasco,M.A. and Serrano,M. (2002) "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J., 21, 6225-6235.
90. Garcia-Cao,I., Garcia-Cao,M., Tomas-Loba,A., Martin-Caballero,J., Flores,J.M., Klatt,P., Blasco,M.A. and Serrano,M. (2006) Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep., 7, 546-552.
91. Matheu,A., Maraver,A., Klatt,P., Flores,I., Garcia-Cao,I., Borras,C., Flores,J.M., Vina,J., Blasco,M.A. et al. (2007) Delayed ageing through damage protection by the Arf/p53 pathway. Nature, 448 375-379.
92. Jones,S.N., Roe,A.E., Donehower,L.A. and Bradley,A. (1995) Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378, 206-208.
93. Montes de Oca Luna,R., Wagner,D.S. and Lozano,G. (1995) Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206.
94. Ringshausen,I., O'Shea,C.C., Finch,A.J., Swigart,L.B. and Evan,G.I. (2006) Mdm2 is critically and continuously required to suppress lethal p53 activity in vivo. Cancer Cell, 10, 501-514.
95. Mendrysa,S.M., O'Leary,K.A., McElwee,M.K., Michalowski,J., Eisenman,R.N., Powell,D.A. and Perry,M.E. (2006) Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev., 20, 16-21.
96. Mendrysa,S.M. and Perry,M.E. (2006) Tumor suppression by p53 without accelerated aging: Just enough of a good thing? Cell cycle (Georgetown, Tex.), 5, 714-717.
97. Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A., Xirodimas,D.P., Saville,M.K. and Lane,D.P. (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev., 19, 2122-2137.
98. Matlashewski,G.J., Tuck,S., Pim,D., Lamb,P., Schneider,J. and Crawford,L.V. (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7, 961-963.
99. Bonafe,M., Salvioli,S., Barbi,C., Trapassi,C., Tocco,F., Storci,G., Invidia,L., Vannini,I, Rossi,M. et al. (2004) The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death. Cell Death Differ. 11, 962-973.
100. Dumont,P., Leu,J.I., Delia Pietra,A.C.III, George,D.L. and Murphy,M. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet., 33, 357-365.
101. van Heemst,D., Mooijaart,S.P., Beekman,M., Schreuder,J., de Craen,A.J., Brandt,B.W., Slagboom,P.E. and Westendorp,R.G. (2005) Variation in the human TP53 gene affects old age survival and cancer mortality. Exp. Gerontol., 40, 11-15.
102. Orsted,D.D., Bojesen,S.E., Tybjaerg-Hansen,A. and Nordestgaard,B.G. (2007) Tumor suppressor p53 Arg72Pro polymorphism and longevity, cancer survival, and risk of cancer in the general population. J. Exp. Med. 204, 1295-1301.